Generation and function of reactive oxygen species in dendritic cells during antigen presentation

被引:211
作者
Matsue, H
Edelbaum, D
Shalhevet, D
Mizumoto, N
Yang, CD
Mummert, ME
Oeda, J
Masayasu, H
Takashima, A
机构
[1] Univ Texas, SW Med Ctr, Dept Dermatol, Dallas, TX 75390 USA
[2] Daiichi Pharmaceut Co Ltd, Tokyo, Japan
关键词
D O I
10.4049/jimmunol.171.6.3010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although reactive oxygen species (ROS) have long been considered to play pathogenic roles in various disorders, this classic view is now being challenged by the recent discovery of their physiological roles in cellular signaling. To determine the immunological consequence of pharmacological disruption of endogenous redox regulation, we used a selenium-containing antioxidant compound ebselen known to modulate both thioredoxin and glutaredoxin pathways. Ebselen at 5-20 muM inhibited Con A-induced proliferation and cytokine production by the HDK-1 T cell line as well as the LPS-triggered cytokine production by XS52 dendritic cell (DC) line. Working with the in vitro-reconstituted Ag presentation system composed of bone marrow-derived DC, CD4(+) T cells purified from DO11.10 TCR-transgenic mice and OVA peptide (serving as Ag), we observed that 1) both T cells and DC elevate intracellular oxidation states upon Ag-specific interaction; 2) ebselen significantly inhibits ROS production in both populations; and 3) ebselen at 5-20 muM inhibits DC-induced proliferation and cytokine production by T cells as well as T cell-induced cytokine production by DC. Thus, Ag-specific, bidirectional DC-T cell communication can be blocked by interfering with the redox regulation pathways. Allergic contact hypersensitivity responses in BALB/c mice to oxazolone, but not irritant contact hypersensitivity responses to croton oil, were suppressed significantly by postchallenge treatment with oral administrations of ebselen (100 mg/kg per day). These results provide both conceptual and technical frameworks for studying ROS-dependent regulation of DC-T cell communication during Ag presentation and for testing the potential utility of antioxidants for the treatment of immunological disease. The Journal of Immunology, 2003.
引用
收藏
页码:3010 / 3018
页数:9
相关论文
共 64 条
  • [1] REDOX REGULATION OF FOS AND JUN DNA-BINDING ACTIVITY INVITRO
    ABATE, C
    PATEL, L
    RAUSCHER, FJ
    CURRAN, T
    [J]. SCIENCE, 1990, 249 (4973) : 1157 - 1161
  • [2] Immunopharmacology of rapamycin
    Abraham, RT
    Wiederrecht, GJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 483 - 510
  • [3] Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling
    Abraham, RT
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) : 330 - 336
  • [4] NEGATIVE REGULATION BY GLUCOCORTICOIDS THROUGH INTERFERENCE WITH A CAMP RESPONSIVE ENHANCER
    AKERBLOM, IE
    SLATER, EP
    BEATO, M
    BAXTER, JD
    MELLON, PL
    [J]. SCIENCE, 1988, 241 (4863) : 350 - 353
  • [5] Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation
    Angelini, G
    Gardella, S
    Ardy, M
    Ciriolo, MR
    Filomeni, G
    Di Trapani, G
    Clarke, F
    Sitia, R
    Rubartelli, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) : 1491 - 1496
  • [6] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [7] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [8] Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
    Barford, D
    Neel, BG
    [J]. STRUCTURE, 1998, 6 (03) : 249 - 254
  • [9] Nitric oxide and the immune response
    Bogdan, C
    [J]. NATURE IMMUNOLOGY, 2001, 2 (10) : 907 - 916
  • [10] Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: Tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
    Brazelton, TR
    Morris, RE
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) : 710 - 720